Correlation of dyskerin expression with active proliferation independent of telomerase

Head and Neck

Volumn 33, Issue 7, 2011, Pages 1041-1051

  Alawi, Faizan ^a   Lin, Ping ^a   Ziober, Barry ^a,b   Patel, Reena ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CENTOCOR INC   (United States)

Author keywords

ALT; oral carcinogenesis; ribosome biogenesis; telomere; TERT

Indexed keywords

DYSKERIN; MESSENGER RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CARCINOGENESIS; CELL IMMORTALIZATION; CELL PROLIFERATION; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; KERATINOCYTE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GERM-LINE MUTATION; HEAD AND NECK NEOPLASMS; HUMANS; KERATINOCYTES; NUCLEAR PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; TELOMERASE; UP-REGULATION;

EID: 79959270500     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21579     Document Type: Article

References (53)

1. Artandi SE, Chang S, Lee SL, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000; 406: 641-645. (Pubitemid 30641052)
2. Chang JT, Chen YL, Yang HT, Chen CY, Cheng AJ,. Differential regulation of telomerase activity by six telomerase subunits. Eur J Biochem 2002; 269: 3442-3450. (Pubitemid 34988987)
3. Patel MM, Parekh LJ, Jha FP, et al. Clinical usefulness of telomerase activation and telomere length in head and neck cancer. Head Neck 2002; 24: 1060-1067. (Pubitemid 35379308)
4. Shay JW, Wright WE,. Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov 2006; 5: 577-584. (Pubitemid 43971192)
5. Reddel RR,. Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett 2003; 194: 155-162. (Pubitemid 36577326)
6. Reddel RR,. An alternative lifestyle for immortalized oral keratinocytes. J Clin Invest 2001; 108: 665-667. (Pubitemid 32906194)
7. Mitchell JR, Wood E, Collins K,. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 1999; 402: 551-555.
8. Montanaro L, Calienni M, Ceccarelli C, et al. Relationship between dyskerin expression and telomerase activity in human breast cancer. Cell Oncol 2008; 30: 483-490.
9. Meier UT,. The many facets of H/ACA ribonucleoproteins. Chromosoma 2005; 114: 1-14. (Pubitemid 40724054)
10. Ruggero D, Grisendi S, Piazza F, et al. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 2003; 299: 259-262. (Pubitemid 36125213)
11. Mochizuki Y, He J, Kulkarni S, Bessler M, Mason PJ,. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc Natl Acad Sci U S A 2004; 101: 10756-10761. (Pubitemid 38955815)
12. Yoon A, Peng G, Brandenburger Y, et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 2006; 312: 902-906. (Pubitemid 43727321)
13. Ruggero D, Pandolfi PP,. Does the ribosome translate cancer? Nat Rev Cancer 2003; 3: 179-192. (Pubitemid 37328870)
14. Piva R, Pellegrino E, Mattioli M, et al. Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. J Clin Invest 2006; 116: 3171-3182. (Pubitemid 44878631)
15. Westermann F, Henrich KO, Wei JS, et al. High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status. Clin Cancer Res 2007; 13: 4695-4703. (Pubitemid 47294775)
16. Montanaro L, Brigotti M, Clohessy J, et al. Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. J Pathol 2006; 210: 10-18. (Pubitemid 44288175)
17. Schaner ME, Ross DT, Ciaravino G, et al. Gene expression patterns in ovarian carcinomas. Mol Biol Cell 2003; 14: 4376-4386. (Pubitemid 37444641)
18. Sieron P, Hader C, Hatina J, et al. DKC1 overexpression associated with prostate cancer progression. Br J Cancer 2009; 101: 1410-1416.
19. Witkowska A, Gumprecht J, Glogowska-Ligus J, et al. Expression profile of significant immortalization genes in colon cancer. Int J Mol Med 2010; 25: 321-329.
20. McDonald SL, Edington HD, Kirkwood JM, Becker D,. Expression analysis of genes identified by molecular profiling of VGP melanomas and MGP melanoma-positive lymph nodes. Cancer Biol Ther 2004; 3: 110-120. (Pubitemid 41342432)
21. Turano M, Angrisani A, De RM, Izzo P, Furia M,. Real-time PCR quantification of human DKC1 expression in colorectal cancer. Acta Oncol 2008; 47: 1598-1599.
22. Alawi F, Lee MN,. DKC1 is a direct and conserved transcriptional target of c-MYC. Biochem Biophys Res Commun 2007; 362: 893-898. (Pubitemid 47390657)
23. Schuhmacher M, Kohlhuber F, Holzel M, et al. The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res 2001; 29: 397-406. (Pubitemid 32060926)
24. Jaatinen T, Hemmoranta H, Hautaniemi S, et al. Global gene expression profile of human cord blood-derived CD133+ cells. Stem Cells 2006; 24: 631-641. (Pubitemid 44464767)
25. Gu BW, Bessler M, Mason PJ,. A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice. Proc Natl Acad Sci U S A 2008; 105: 10173-10178.
26. Cao Y, Huschtscha LI, Nouwens AS, et al. Amplification of telomerase reverse transcriptase gene in human mammary epithelial cells with limiting telomerase RNA expression levels. Cancer Res 2008; 68: 3115-3123.
27. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279: 349-352. (Pubitemid 28063364)
28. Dickson MA, Hahn WC, Ino Y, et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000; 20: 1436-1447. (Pubitemid 30069263)
29. Opitz OG, Suliman Y, Hahn WC, Harada H, Blum HE, Rustgi AK,. Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism. J Clin Invest 2001; 108: 725-732. (Pubitemid 32906201)
30. Kraemer K, Fuessel S, Schmidt U, et al. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin Cancer Res 2003; 9: 3794-3800. (Pubitemid 37169250)
31. Ziober AF, Patel KR, Alawi F, et al. Identification of a gene signature for rapid screening of oral squamous cell carcinoma. Clin Cancer Res 2006; 12: 5960-5971. (Pubitemid 44703755)
32. Knight SW, Heiss NS, Vulliamy TJ, et al. X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet 1999; 65: 50-58. (Pubitemid 30470448)
33. Su AI, Cooke MP, Ching KA, et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A 2002; 99: 4465-4470. (Pubitemid 34286008)
34. Choi J, Southworth LK, Sarin KY, et al. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet 2008; 4: e10.
35. Smith LL, Coller HA, Roberts JM,. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 2003; 5: 474-479. (Pubitemid 36592272)
36. Tilman G, Loriot A, Van Beneden A, et al. Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells. Oncogene 2009; 28: 1682-1693.
37. Hess NS, Knight SW, Vulliamy TJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998; 19: 32-38. (Pubitemid 28242019)
38. Knight S, Vulliamy T, Copplestone A, Gluckman E, Mason P, Dokal I,. Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol 1998; 103: 990-996. (Pubitemid 29012634)
39. Packer BR, Yeager M, Burdett L, et al. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 2006; 34: D617-D621.
40. Bullwinkel J, Baron-Lühr B, Lüdemann A, Wohlenberg C, Gerdes J, Scholzen T,. Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol 2006; 206: 624-635. (Pubitemid 43191037)
41. Venteicher AS, Meng Z, Mason PJ, Veenstra TD, Artandi SE,. Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell 2008; 132: 945-957. (Pubitemid 351381739)
42. Wu KJ, Grandori C, Amacker M, et al. Direct activation of TERT transcription by c-MYC. Nat Genet 1999; 21: 220-224. (Pubitemid 29070372)
43. Wu CH, Sahoo D, Arvanitis C, Bradon N, Dill DL, Felsher DW,. Combined analysis of murine and human microarrays and ChIP analysis reveals genes associated with the ability of MYC to maintain tumorigenesis. PLoS Genet 2008; 4: e1000090.
44. Kyo S, Takakura M, Fujiwara T, Inoue M,. Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci 2008; 99: 1528-1538.
45. Wong JM, Collins K,. Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. Genes Dev 2006; 20: 2848-2858. (Pubitemid 44771746)
46. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ,. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998; 396: 84-88. (Pubitemid 28520454)
47. Sears RC, Nevins JR,. Signaling networks that link cell proliferation and cell fate. J Biol Chem 2002; 277: 11617-11620. (Pubitemid 34952710)
48. Zeller KI, Zhao X, Lee CW, et al. Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci U S A 2006; 103: 17834-17839. (Pubitemid 44852246)
49. Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006; 354: 2419-2430. (Pubitemid 43855045)
50. Poncet D, Belleville A, t'kint de Roodenbeke C, et al. Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia. Blood 2008; 111: 2388-2391. (Pubitemid 351451451)
51. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z,. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 2006; 38: 1043-1048. (Pubitemid 44325930)
52. Alawi F, Lin P,. Loss of dyskerin reduces the accumulation of a subset of H/ACA snoRNA-derived miRNA. Cell Cycle 2010; 9: 2467-2469.
53. Bartel DP,. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.